M2 PHARMA-October 18, 2016-Edico Genome Provides Dragen Bio-IT Processor to Johns Hopkins
REDONDA MILLER, MD, MBA, is now president of Johns Hopkins
Hospital in Baltimore, Maryland.
is now working with Johns Hopkins
HealthCare (JHHC) to upgrade their core administrative systems, enabling them to better serve their membership and provider network.
Direct Energy is to help deliver a new solar project that will produce affordable and reliable solar energy to power the Johns Hopkins
Medicine facilities in Baltimore, United States.
SAUDI Aramco, a fully integrated global energy and chemicals enterprise, and Johns Hopkins
Medicine, a leading US academic health system with extensive experience in elevating care delivery worldwide, has inaugurated a first-of-its-kind healthcare joint venture in Dhahran, Saudi Arabia.
Global Banking News-May 24, 2013--FIRST FULL 'GENES TO SOCIETY' CLASS OF JOHNS HOPKINS
MEDICAL STUDENTS GRADUATES ON MAY 23(C)2013 ENPublishing - http://www.
Ball, RN, MAS, recently became the first nurse in the history of Johns Hopkins
Medicine to have an inpatient unit named in her honor.
For the 21st year in a row, The Johns Hopkins
Hospital has taken the top spot in US News & World Report's annual rankings of American hospitals, placing first in five medical specialties and in the top five in 10 others.
About Johns Hopkins
MedicineA more than $4 billion enterprise, Johns Hopkins
Medicine unites physicians and scientists of the Johns Hopkins
University School of Medicine with the organizations, health professionals and facilities of the Johns Hopkins
Elias Zerhouni, MD, the director of the National Institutes of Health (NIH) from 2002 to 2008 and former Johns Hopkins
Medicine Executive Vice Dean, rejoined Johns Hopkins
Medicine this month as a senior advisor.
Abu Dhabi: Twenty Emiratis have been selected by the Health Authority Abu Dhabi (HAAD) to participate in a health care leadership training programme sourced from Johns Hopkins
Bloomberg School of Public Health.
Biogen Idec (NASDAQ: BIIB), Cambridge, Mass, has announced a research collaboration with the newly formed Brain Science Institute at Johns Hopkins
University to discover and develop therapies for neurodegenerative diseases such as multiple sclerosis, Alzheimer's and Parkinson's.